Raymond James & Associates’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $21.9K | Sell |
|
|||||
|
2024
Q2 | $37.7K | Sell |
|
|||||
|
2024
Q1 | $64.3K | Sell |
|
|||||
|
2023
Q4 | $31.6K | Sell |
|
|||||
|
2023
Q3 | $27.6K | Sell |
|
|||||
|
2023
Q2 | $339K | Sell |
|
|||||
|
2023
Q1 | $544K | Sell |
|
|||||
|
2022
Q4 | $349K | Sell |
|
|||||
|
2022
Q3 | $1.08M | Buy |
|
|||||
|
2022
Q2 | $517K | Sell |
|
|||||
|
2022
Q1 | $640K | Buy |
|
|||||
|
2021
Q4 | $758K | Sell |
|
|||||
|
2021
Q3 | $659K | Buy |
|
|||||
|
2021
Q2 | $759K | Buy |
|
|||||
|
2021
Q1 | $749K | Sell |
|
|||||
|
2020
Q4 | $1.57M | Buy |
|
|||||
|
2020
Q3 | $4.88M | Buy |
|
|||||
|
2020
Q2 | $2.85M | Buy |
|
|||||
|
2020
Q1 | $932K | Buy |
|
|||||
|
2019
Q4 | $520K | Buy |
|
|||||
|
2019
Q3 | $338K | Buy |
|